Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 in the page footer, with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T08:00:59.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The government funding operating-status notice has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-19T08:38:44.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The screenshots show only minor UI/layout updates without any changes to core study content such as title, conditions, interventions, outcomes, eligibility criteria, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:15:15.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Update refresh: new operating-status notice and newer date/version metadata; removal of older last-update and disease-specific items.
    Difference
    4%
    Check dated 2025-10-06T16:07:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Updated terminology from Plasma cell myeloma to Multiple myeloma and bumped the revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T10:11:05.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-15T01:06:50.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.